{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T09:59:52Z","timestamp":1768384792000,"version":"3.49.0"},"reference-count":30,"publisher":"CSIRO Publishing","issue":"4","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":1071,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,13]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Over the 15 years since the 45 and Up Study (the Study) was established, researchers have harnessed its capacity for enabling rigorous, comprehensive investigation of cancer causes, care, and outcomes. For the first time in Australia, the entire cancer-control continuum could be investigated by linking questionnaire data with cancer registry notifications, hospital records, outpatient medical services and prescription medications at scale. Here, we use lung cancer as a case study to demonstrate the Study\u2019s potential to improve cancer control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>Narrative description.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Between 2006\u20132013, approximately 1200 participants in the Study cohort who had no prior history of cancer were diagnosed with lung cancer, allowing the generation of novel, policy- and practice-relevant evidence for tobacco control, screening, and systems of care. The Study produced evidence on the continuing impact of smoking, including that \u2018light smoking\u2019 (1\u20135 cigarettes\/day) is associated with nine times the risk of lung cancer compared to never-smoking; and that 54% of lung cancers could be avoided long-term if all Australians who smoked were to quit. The Study was used to validate a lung cancer screening risk prediction tool, correctly identifying 70% of the participants with a history of smoking who developed lung cancer within a 6-year period as \u2018high-risk\u2019. Potential inequities in lung cancer care were identified using the Study cohort, including suboptimal levels of radiotherapy utilisation, below benchmark levels of systemic therapy for patients with metastatic disease, and high numbers of emergency department presentations prior to diagnosis. Participants with lung cancer reported poorer quality of life than those with almost any other cancer type, and about 50% reported severe physical functioning limitations. The Study also provided the infrastructure for the first comprehensive report on lung cancer health system costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons learnt:<\/jats:title>\n                    <jats:p>As a statewide, population-based cohort, the Study provides reliable estimates of cancer risk, health services utilisation, and person-centred outcomes that can inform policy and practice decision making; and has provided the backbone for localising policy-relevant insights from international experience. We have found that the direct involvement of clinicians and policy makers in research design, and engagement with community networks, can yield tractable, policy-relevant, and ultimately impactful scientific insights.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.17061\/phrp3242232","type":"journal-article","created":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T17:23:16Z","timestamp":1670779396000},"source":"Crossref","is-referenced-by-count":0,"title":["Capacity of the 45 and Up Study to mobilise evidence-based improvements in cancer control: lung cancer case study"],"prefix":"10.1071","volume":"32","author":[{"given":"Marianne","family":"Weber","sequence":"first","affiliation":[{"name":"A The Daffodil Centre, University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preston","family":"Ngo","sequence":"additional","affiliation":[{"name":"A The Daffodil Centre, University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Banks","sequence":"additional","affiliation":[{"name":"A The Daffodil Centre, University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Steinberg","sequence":"additional","affiliation":[{"name":"A The Daffodil Centre, University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goldsbury","sequence":"additional","affiliation":[{"name":"A The Daffodil Centre, University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Grogan","sequence":"additional","affiliation":[{"name":"A The Daffodil Centre, University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Canfell","sequence":"additional","affiliation":[{"name":"B National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"2026011323573101800_R1","doi-asserted-by":"crossref","unstructured":"Million Women Study Collaborative Group. The Million Women Study: design and characteristics of the study population. Breast Cancer Res. 1999;1:73\u201380. CrossRef | PubMed","DOI":"10.1186\/bcr16"},{"key":"2026011323573101800_R2","unstructured":"Australian Institute of Health and Welfare. Australian Burden of Disease Study: impact and causes of illness and death in Australia 2018. Canberra: AIHW, 2021 [cited 2022 Nov 1]. Available from: www.aihw.gov.au\/reports\/burden-of-disease\/abds-impact-and-causes-of-illness-and-death-in-aus\/summary"},{"key":"2026011323573101800_R3","unstructured":"Australian Institute of Health and Welfare. National Drug Strategy Household Survey 2019. Canberra, ACT: AIHW, 2020 [cited 2022 Nov 1]. Available from: www.aihw.gov.au\/getmedia\/77dbea6e-f071-495c-b71e-3a632237269d\/aihw-phe-270.pdf.aspx?inline=true"},{"key":"2026011323573101800_R4","doi-asserted-by":"crossref","unstructured":"Baenziger ON, Ford L, Yazidjoglou A, Joshy G, Banks E. E-cigarette use and combustible tobacco cigarette smoking uptake among non-smokers, including relapse in former smokers: umbrella review, systematic review and meta-analysis. BMJ Open 2021;11:e045603. CrossRef | PubMed","DOI":"10.1136\/bmjopen-2020-045603"},{"key":"2026011323573101800_R5","doi-asserted-by":"crossref","unstructured":"Luo Q, Steinberg J, O\u2019Connell DL, Yu XQ, Caruana M, Wade S, et al. Lung cancer mortality in Australia in the twenty-first century: How many lives can be saved with effective tobacco control? Lung Cancer. 2019;130:208\u201315. CrossRef | PubMed","DOI":"10.1016\/j.lungcan.2019.02.028"},{"key":"2026011323573101800_R6","doi-asserted-by":"crossref","unstructured":"National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395\u2013409. CrossRef | PubMed","DOI":"10.1056\/NEJMoa1102873"},{"key":"2026011323573101800_R7","doi-asserted-by":"crossref","unstructured":"de Koning HJ, van der Aalst CM, de Jong PA, Scholten EG, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382:503\u201313. CrossRef | PubMed","DOI":"10.1056\/NEJMoa1911793"},{"key":"2026011323573101800_R8","unstructured":"Cancer Australia. Report on the Lung Cancer Screening Enquiry. Sydney, NSW: Cancer Australia; 2020 [cited 2022 Sep 23]. Available from: www.canceraustralia.gov.au\/publications-and-resources\/cancer-australia-publications\/report-lung-cancer-screening-enquiry"},{"key":"2026011323573101800_R9","unstructured":"Australian Institute of Health and Welfare. Disease expenditure in Australia 2018\u201319. Canberra: AIHW, 2021 [cited 2022 Nov 1]. Available from: www.aihw.gov.au\/reports\/health-welfare-expenditure\/spending-on-disease-in-australia\/contents\/about"},{"key":"2026011323573101800_R10","doi-asserted-by":"crossref","unstructured":"Weber MF, Sarich PEA, Vaneckova P, Wade S, Egger S, Ngo P, et al. Cancer incidence and cancer death in relation to tobacco smoking in a population-based Australian cohort study. Int J Cancer. 2021;149:1076\u201388. CrossRef | PubMed","DOI":"10.1002\/ijc.33685"},{"key":"2026011323573101800_R11","doi-asserted-by":"crossref","unstructured":"Laaksonen MA, Canfell K, MacInnis R, Arriaga ME, Banks E, Magliano DJ, et al. The future burden of lung cancer attributable to current modifiable behaviours: a pooled study of seven Australian cohorts. Int J Epidemiol. 2018;47:1772\u201383. CrossRef | PubMed","DOI":"10.1093\/ije\/dyy136"},{"key":"2026011323573101800_R12","doi-asserted-by":"crossref","unstructured":"Banks E, Joshy G, Weber MF, Liu B, Grenfell R, Egger S, et al. Tobacco smoking and all-cause mortality in a large Australian cohort study: findings from a mature epidemic with current low smoking prevalence. BMC Med. 2015;13:38. CrossRef | PubMed","DOI":"10.1186\/s12916-015-0281-z"},{"key":"2026011323573101800_R13","doi-asserted-by":"crossref","unstructured":"Thurber KA, Banks E, Joshy G, Soga K, Marmor A, Benton G, et al. Tobacco smoking and mortality among Aboriginal and Torres Strait Islander adults in Australia. Int J Epidemiol. 2021;50:942\u201354. CrossRef | PubMed","DOI":"10.1093\/ije\/dyaa274"},{"key":"2026011323573101800_R14","doi-asserted-by":"crossref","unstructured":"Alberg AJ, Shopland DR, Cummings KM. The 2014 Surgeon General\u2019s report: commemorating the 50th Anniversary of the 1964 Report of the Advisory Committee to the US Surgeon General and updating the evidence on the health consequences of cigarette smoking. Am J Epidemiol. 2014;179:403\u201312. CrossRef | PubMed","DOI":"10.1093\/aje\/kwt335"},{"key":"2026011323573101800_R15","unstructured":"World Health Organization. Report on the global tobacco epidemic 2021: addressing new and emerging products. Geneva: WHO; 2021 [cited 2022 Nov 1]. Available from: www.who.int\/publications\/i\/item\/9789240032095"},{"key":"2026011323573101800_R16","doi-asserted-by":"crossref","unstructured":"Wilkinson AL, Scollo MM, Wakefield MA, Spitall MJ, Chaloupka FJ, Durkin SJ. Smoking prevalence following tobacco tax increases in Australia between 2001 and 2017: an interrupted time-series analysis. Lancet Public Health. 2019;4:e618\u201327. CrossRef | PubMed","DOI":"10.1016\/S2468-2667(19)30203-8"},{"key":"2026011323573101800_R17","doi-asserted-by":"crossref","unstructured":"Thomas DP, McMahon E, Wang Z, Scollo MM, Durkin SJ. Impact of three annual tobacco tax rises on tobacco sales in remote Australian Aboriginal community stores. Tob Control. 2021;30:e122\u20137. CrossRef | PubMed","DOI":"10.1136\/tobaccocontrol-2020-055865"},{"key":"2026011323573101800_R18","unstructured":"Cancer Australia. National Cancer Control Indicators. Sydney: Cancer Australia; 2022. [cited 2021 Nov 26]. Available from: ncci.canceraustralia.gov.au\/outcomes\/relative-survival-rate\/5-year-relative-survival"},{"key":"2026011323573101800_R19","doi-asserted-by":"crossref","unstructured":"Weber M, Yap S, Goldsbury D, Manners D, Tammemagi M, Marshall H, et al. Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOm2012 risk prediction tool. Int J Cancer. 2017;141:242\u201353. CrossRef | PubMed","DOI":"10.1002\/ijc.30673"},{"key":"2026011323573101800_R20","doi-asserted-by":"crossref","unstructured":"Goldsbury DE, Weber MF, Yap S, Rankin NM, Ngo P, Verman L, et al. Health services costs for lung cancer care in Australia: estimates from the 45 and Up Study. PLoS One. 2020;15:e0238018. CrossRef | PubMed","DOI":"10.1371\/journal.pone.0238018"},{"key":"2026011323573101800_R21","doi-asserted-by":"crossref","unstructured":"Rankin NM, McWilliams A, Marshall HM. Lung cancer screening implementation: Complexities and priorities. Respirology. 2020;25 Suppl 2:5\u201323. CrossRef | PubMed","DOI":"10.1111\/resp.13963"},{"key":"2026011323573101800_R22","doi-asserted-by":"crossref","unstructured":"Creighton N, Purdie S, Soeberg M, Walton R, Baker D, Young J. Self-selection in a population-based cohort study: impact on health service use and survival for bowel and lung cancer assessed using data linkage. BMC Med Res Methodol 2018;18:84. CrossRef | PubMed","DOI":"10.1186\/s12874-018-0537-3"},{"key":"2026011323573101800_R23","doi-asserted-by":"crossref","unstructured":"Cheng ES, Weber MF, Steinberg J, Canfell K, Yu XQ. Evaluating risk factors for lung cancer among never-smoking individuals using two Australian studies. J Cancer Res Clin Oncol. 2022;148(10):2827\u201340 CrossRef | PubMed","DOI":"10.1007\/s00432-022-04043-9"},{"key":"2026011323573101800_R24","doi-asserted-by":"crossref","unstructured":"Purdie S, Creighton N, White KM, Baker D, Ewald D, Lee CK, et al. Pathways to diagnosis of non-small cell lung cancer: a descriptive cohort study. NPJ Prim Care Resp Med. 2019;29:2. CrossRef | PubMed","DOI":"10.1038\/s41533-018-0113-7"},{"key":"2026011323573101800_R25","doi-asserted-by":"crossref","unstructured":"Yap S, Goldsbury D, Yap ML, Yuill S, Rankin N, Weber M, et al. Patterns of care and emergency presentations for people with non-small cell lung cancer in New South Wales, Australia: a population-based study. Lung Cancer. 2018;122:171\u20139. CrossRef | PubMed","DOI":"10.1016\/j.lungcan.2018.06.006"},{"key":"2026011323573101800_R26","doi-asserted-by":"crossref","unstructured":"Yap ML, O\u2019Connell DL, Goldsbury D, Weber M, Barton M. Comparison of four methods for estimating actual radiotherapy utilisation using the 45 and up study cohort in New South Wales, Australia. Radiother Oncol. 2019;131:14\u201320. CrossRef | PubMed","DOI":"10.1016\/j.radonc.2018.10.039"},{"key":"2026011323573101800_R27","doi-asserted-by":"crossref","unstructured":"Ngo P, Goldsbury DE, Karikios D, Yap S, Yap ML, Egger S, et al. Lung cancer treatment patterns and factors relating to systemic therapy use in Australia. Asia Pac J Clin Oncol. 2022;18(5):e235\u201346. CrossRef | PubMed","DOI":"10.1111\/ajco.13637"},{"key":"2026011323573101800_R28","doi-asserted-by":"crossref","unstructured":"Joshy G, Thandrayen J, Koczwara B, Butow P, Laidsaar-Powell R, Rankin N, et al. Disability, psychological distress and quality of life in relation to cancer diagnosis and cancer type: population-based study of 22,505 cancer survivors and 244,000 people without cancer. BMC Med. 2020;18:372. CrossRef | PubMed","DOI":"10.1186\/s12916-020-01830-4"},{"key":"2026011323573101800_R29","doi-asserted-by":"crossref","unstructured":"Tran B, Vajdic CM, Webber K, Laaksonen MA, Stavrou EP, Tiller K, et al. Self-reported health, lifestyle and social circumstances of Australian adult cancer survivors: A propensity score weighted cross-sectional study. Cancer Epidemiol. 2020;67:101773. CrossRef | PubMed","DOI":"10.1016\/j.canep.2020.101773"},{"key":"2026011323573101800_R30","doi-asserted-by":"crossref","unstructured":"Thandrayen J, Joshy G, Stubbs J, Bailey L, Butow P, Koczwara B, et al. Workforce participation in relation to cancer diagnosis, type and stage: Australian population-based study of 163,556 middle-aged people. J Cancer Surviv. 2022;16(2):461\u201373. CrossRef | PubMed","DOI":"10.1007\/s11764-021-01041-7"}],"container-title":["Public Health Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/pu\/article-pdf\/doi\/10.17061\/phrp3242232\/1822194\/pu19397.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/pu\/article-pdf\/doi\/10.17061\/phrp3242232\/1822194\/pu19397.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:57:39Z","timestamp":1768366659000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/pu\/article\/32\/4\/e3242232\/265378\/Capacity-of-the-45-and-Up-Study-to-mobilise"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12,13]]}},"URL":"https:\/\/doi.org\/10.17061\/phrp3242232","relation":{},"ISSN":["2204-2091"],"issn-type":[{"value":"2204-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"article-number":"e3242232"}}